Orangecross Homehealth Profile
Key Indicators
- Authorised Capital ₹ 1.20 Cr
as on 26-06-2024
- Paid Up Capital ₹ 6.67 M
as on 26-06-2024
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 113.73%
(FY 2023)
- Profit 36.89%
(FY 2023)
- Ebitda 41.91%
(FY 2023)
- Net Worth -40.09%
(FY 2023)
- Total Assets 62.64%
(FY 2023)
About Orangecross Homehealth
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 Cr and a paid-up capital of Rs 6.67 M, as per Ministry of Corporate Affairs (MCA) records.
Parthasarathi Patnaik, Ajaya Bhanja, Manmadha Rao, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100OR2017PTC027935
- Company No.
027935
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 2017
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Bhubaneswar, Orissa, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Orangecross Homehealth?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajaya Bhanja  | Managing Director | 21-Nov-2017 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Santosh Jena | Director | 21-Nov-2017 | Current |
| Parthasarathi Patnaik | Director | 21-Nov-2017 | Current |
| Manmadha Rao | Director | 21-Nov-2017 | Current |
Financial Performance of Orangecross Homehealth.
Orangecross Homehealth Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 113.73% increase. The company also saw a substantial improvement in profitability, with a 36.89% increase in profit. The company's net worth observed a substantial decline by a decrease of 40.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orangecross Homehealth?
In 2023, Orangecross Homehealth had a promoter holding of 90.36% and a public holding of 9.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Orangecross Homehealth?
Orangecross Homehealth has a workforce of 59 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orangecross Homehealth, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orangecross Homehealth's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
